Publications

We introduce the following growing list of publications from the KCGD. The list contains the studies which used the Korean cancer patient data produced by KCGD.



Kim SK, Hwan Kim J, Yun SJ, Kim WJ, Kim SY. APPEX: analysis platform for the identification of prognostic gene expression signatures in cancer.  Bioinformatics. 2014 Nov 15;30(22):3284-6. Epub 2014 Aug 4. PMID: 25091586


Kim SK, Roh YG, Park K, Kang TH, Kim WJ, Lee JS, Leem SH, Chu IS. Expression signature defined by FOXM1-CCNB1 activation predicts disease recurrence in non-muscle-invasive bladder cancer. Clin Cancer Res. 2014 Jun 15;20(12):3233-43.  Epub 2014 Apr 8. PMID: 24714775


Kim SK, Yun SJ, Kim J, Lee OJ, Bae SC, Kim WJ. Identification of gene expression signature modulated by nicotinamide in a mouse bladder cancer model. PLoS One. 2011;6(10):e26131. Epub 2011 Oct 10. PMID: 22028816 


Cho JY, Lim JY, Cheong JH, Park YY, Yoon SL, Kim SM, Kim SB, Kim H, Hong SW, Park YN, Noh SH, Park ES, Chu IS, Hong WK, Ajani JA, Lee JS. Gene expression signature-based prognostic risk score in gastric cancer. Clin Cancer Res. 2011 Apr 1;17(7):1850-7. Epub 2011 Mar 29. PMID:21447720


Kim WJ, Kim SK, Jeong P, Yun SJ, Cho IC, Kim IY, Moon SK, Um HD, Choi YH. A four-gene signature predicts disease progression in muscle invasive bladder cancer. Mol Med. 2011 May-Jun;17(5-6):478-85. Epub 2011 Feb 4. PMID: 21308147

 

Lee JS, Leem SH, Lee SY, Kim SC, Park ES, Kim SB, Kim SK, Kim YJ, Kim WJ, Chu IS. Expression signature of E2F1 and its associated genes predicts superficial-to-invasive progression of bladder tumors. J Clin Oncol. 2010 Jun 1;28(16):2660-7. Epub 2010 Apr 26. PMID:20421545